Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. GNW
GNW logo

GNW Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Genworth Financial Inc (GNW) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.250
1 Day change
-1.08%
52 Week Range
9.280
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Genworth Financial Inc (GNW) is not a strong buy at this moment for a beginner, long-term investor. The technical indicators are neutral, options data does not indicate strong bullish sentiment, and the company's financial performance shows a significant decline in net income. There are no strong positive catalysts or recent influential trades to support a buy decision.

Technical Analysis

The MACD is negative and contracting (-0.0273), RSI is neutral at 45.298, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot point of 8.52, with support at 8.249 and resistance at 8.792.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low Put-Call ratios suggest a lack of bearish sentiment, but the overall trading volume and open interest do not indicate strong bullish activity.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
8
Buy
3

Positive Catalysts

  • The CareScout 2025 Cost of Care Survey indicates an increase in the cost of assisted living and caregiver services, which could indirectly benefit the company's long-term care insurance business.

Neutral/Negative Catalysts

  • The company's net income dropped significantly (-300% YoY) in Q4 2025, and there is no recent congress or insider trading activity to suggest confidence in the stock. Additionally, the stock has a 30% chance of declining further in the short term.

Financial Performance

In Q4 2025, revenue increased slightly by 0.39% YoY to $1.784 billion, but net income dropped drastically by -300% YoY to $2 million. EPS remained flat at 0.01, and gross margin showed no improvement.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes are available for GNW.

Wall Street analysts forecast GNW stock price to rise
1 Analyst Rating
Wall Street analysts forecast GNW stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 8.340
sliders
Low
10
Averages
10
High
10
Current: 8.340
sliders
Low
10
Averages
10
High
10
Keefe Bruyette
Keefe
Market Perform -> Outperform
upgrade
$9
AI Analysis
2025-06-18
Reason
Keefe Bruyette
Keefe
Price Target
$9
AI Analysis
2025-06-18
upgrade
Market Perform -> Outperform
Reason
Keefe Bruyette upgraded Genworth to Outperform from Market Perform with a price target of $9, up from $8.50. The company could potentially recover $500M, or $1.25 per share, related to a European payment protection business it previously sold to AXA, and a counter lawsuit between AXA and Santander, the analyst tells investors in a research note. The firm says a ruling is expected mid-to-late summer, and proceeds could total as much as 15%-20% of Genworth's market capitalization. In addition, Genworth currently trades at a 22% discount to its implied sum-of-the-parts with no lawsuit recovery, greater than the 15% average discount since mid-2023, notes Keefe.
Keefe Bruyette
Market Perform
maintain
$8
2025-05-13
Reason
Keefe Bruyette
Price Target
$8
2025-05-13
maintain
Market Perform
Reason
Keefe Bruyette raised the firm's price target on Genworth to $8.50 from $8 and keeps a Market Perform rating on the shares. The firm revised several life insurer EPS estimates and price targets following Q1 results.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for GNW
Unlock Now

People Also Watch